Home / Publication / A Pharmacokinetic/Viral Kinetic Model to Evaluate Treatment of Chronic HCV Infection with a Non-nucleoside Polymerase Inhibitor

論文

A Pharmacokinetic/Viral Kinetic Model to Evaluate Treatment of Chronic HCV Infection with a Non-nucleoside Polymerase Inhibitor

Author(s): Laetitia Canini, Annabelle Lemenuel-Diot, Barbara J. Brennan, Patrick F. Smith, Alan S. Perelson

Year: 2017年1月10日

Unlocking the Power of Oligonucleotide Therapeutics: A Model-Informed Approach with Certara & Ionis

オンデマンド・ウェビナー

AUC（線形および対数線形）の計算

ブログ

Accumulation: What It Means and How to Calculate It

ブログ

Blending Science & Impact in Drug Development: Felix Boakye-Agyeman, Vice President of the QSS Division at Certara

ビデオ

Powered by Translations.com GlobalLink Web Software

A Pharmacokinetic/Viral Kinetic Model to Evaluate Treatment of Chronic HCV Infection with a Non-nucleoside Polymerase Inhibitor

A Pharmacokinetic/Viral Kinetic Model to Evaluate Treatment of Chronic HCV Infection with a Non-nucleoside Polymerase Inhibitor

Unlocking the Power of Oligonucleotide Therapeutics: A Model-Informed Approach with Certara & Ionis

AUC（線形および対数線形）の計算

Accumulation: What It Means and How to Calculate It

Blending Science & Impact in Drug Development: Felix Boakye-Agyeman, Vice President of the QSS Division at Certara

メルマガ登録

クイックアクセス

ソリューション

お問合せ